| Application no. and date | 05006627.3 (espacenet) (Federated) (European Patent Register), 20010411 | | Patent/reg. no. and date | DK/EP 1576963, 20101124 | | Publication date | 20050921 | | Priority no. and date | US 550371, 20000414 | | EP pub. no. and date |
EP 1576963 20050921 | | Effective date | | | Applicant/owner | ALLERGAN, INC., 2525 Dupont Drive
Irvine CA 92612, US | | Applicant ref. no. | 140124 | | Inventor | CUI, Minglei, 25851 Majorca Way
Mission Viejo, CA 92692, US,
JENKINS, Stephen, 26481 Via Marina
Mission Viejo, CA 92691, US,
AOKI, Kei, Roger, 2 Ginger Lily Court
Coto de Caza, CA 92679, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 38/16 (2006.01) , A61K 38/48 (2006.01) , A61P 29/02 (2006.01) | | Title | Anvendelse af botulinustoxin til behandling af en af infektion forårsaget smerte | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
